Mouse Anti-Human CR2 Monoclonal Antibody (TJL-161)(Cat#: CTMM-0322-JL1553)

This product is an unconjugated anti-Human Complement CR2 Monoclonal antibody (TJL-161) generated from the Mouse. The antibody can be used for WB, IHC(P), ICC/IF, Flow.

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

Summary Related Products & Services

Specifications
Clonality Monoclonal
Clone TJL-161
Host Animal Mouse
Isotype IgG1, kappa
Immunogen Recombinant Human CR2, a.a.142-240
Species Reactivity Human
Applications WB; IHC(P); ICC/IF; Flow
Application Notes WB: 1-2 µg/mL
IHC(P): 1-2 µg/mL
ICC/IF: 1-2 µg/mL
Flow: 1-2 µg/106 cells
Specificity This antibody reacts with Human Complement CR2.
Purity ≥95% as determined by SDS-PAGE
Conjugation Unconjugated
Format Liquid
Size 100 µg
Storage Store at 4°C for short term. Store at -20°C for long term. Avoid freeze-thaw cycle.
Type Primary Antibody
Target
Target Name CR2
Alternative Names Complement C3d Receptor 2; Complement Component (3d/Epstein Barr Virus) Receptor 2; Complement Component 3d Receptor 2; Epstein-Barr Virus Receptor; EBV Receptor; Complement C3d Receptor; CD21 Antigen; Cr2; CR; C3DR; CD21; CVID7; SLEB9
Gene ID 1380
UniProt ID P17927
Information
Introduction omplement receptor type 2 (CR2), also known as complement C3d receptor, Epstein-Barr virus receptor, and CD21 (cluster of differentiation 21), is a protein that in humans is encoded by the CR2 gene. CR2 is involved in the complement system. It binds to iC3b (inactive derivative of C3b), C3dg, or C3d. B cells have CR2 receptors on their surfaces, allowing the complement system to play a role in B-cell activation and matuRation. it is receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU, and participates in B lymphocytes activation.
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry